EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitochondrial Diseases: Molecular Pathogenesis and Therapeutic Advances

Jialun Mei, Peng Ding, Chuan Gao, Jian Zhou, Zhiwei Li, Changqing Zhang, Junjie Gao iD

MedComm · 2025-09 · 6 (9)

DOI: 10.1002/mco2.70385 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 12.09.2025. Verfasst von Jialun Mei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 192 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial diseases are a heterogeneous group of inherited disorders caused by pathogenic variants in mitochondrial DNA (mtDNA) or nuclear genes encoding mitochondrial proteins, culminating in defective oxidative phosphorylation and multisystem involvement. Key pathogenic mechanisms include heteroplasmy driven threshold effects, excess reactive oxygen species, disrupted mitochondrial dynamics and mitophagy, abnormal calcium signaling, and compromised mtDNA repair, which together cause tissue‐specific energy failure in high demand organs. Recent advances have expanded the therapeutic landscape. Precision mitochondrial genome editing—using mitochondrial zinc finger nucleases, mitochondrial transcription activator‐like effector nucleases, DddA‐derived cytosine base editor, and other base editing tools—enables targeted correction or rebalancing of mutant genomes, while highlighting challenges of delivery and off‐target effects. In parallel, metabolic modulators (e.g., coenzyme Q10, idebenone, EPI‐743) aim to restore bioenergetics, and mitochondrial replacement technologies and transplantation are being explored. Despite these promising strategies, major challenges remain, including off‐target effects, precise delivery, and ethical considerations. Addressing these issues through multidisciplinary research and clinical translation holds promise for transforming mitochondrial disease management and improving patient outcomes. By bridging the understanding of mitochondrial dysfunction with advanced therapeutic interventions, this review aims to shed light on effective solutions for managing these complex disorders.

Schlagwörter

Stichwörter der Autor:innen

base editinggene therapygenetic medicinemitochondrial DNA (mtDNA)mitochondrial diseasesmitochondrial gene editingtherapeutic strategies

Autor:innen und Institutionen

  • Department of Orthopaedics Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China.
  • Institute of Microsurgery on Extremities and Department of Orthopedic Surgery Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China.
  • Division of Hepatobiliary and Pancreatic Surgery Department of Surgery The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou Zhejiang China.

ORCID-Profile: Junjie Gao

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Mei, J., Ding, P., Gao, C., Zhou, J., Li, Z., Zhang, C., & Gao, J. (2025). Mitochondrial Diseases: Molecular Pathogenesis and Therapeutic Advances. MedComm, 6(9). https://doi.org/10.1002/mco2.70385

Vancouver

Mei J, Ding P, Gao C, Zhou J, Li Z, Zhang C, et al. Mitochondrial Diseases: Molecular Pathogenesis and Therapeutic Advances. MedComm. 2025;6(9). doi:10.1002/mco2.70385

BibTeX
@article{Mei2025,
  author = {Mei, Jialun and Ding, Peng and Gao, Chuan and Zhou, Jian and Li, Zhiwei and Zhang, Changqing and Gao, Junjie},
  title = {Mitochondrial Diseases: Molecular Pathogenesis and Therapeutic Advances},
  journal = {MedComm},
  year = {2025},
  volume = {6},
  number = {9},
  doi = {10.1002/mco2.70385}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche